Stock Rich List
#2219 on the rich list of 14,644 insiders

Michael Schmertzler

Director at PTC Therapeutics; Director at Hamilton Lane. Based in Warren, New Jersey.

$60.6M
in disclosed stock, −$1.6M (−2.62%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
2219th of 14,644
Companies held
2
Largest holding
HLNE, 84.3% of total
Latest SEC filing
Oct 14, 2026
Listed but not counted
$75.3M

What the $60.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Hamilton Lane HLNE
Class B Common Stock
Directly600,000$84.98$51.0M84.1%Form 4, Sep 16, 2026
PTC Therapeutics PTCT
Common Stock
Directly163,266$58.33$9.5M15.7%Form 4, Oct 14, 2026
Hamilton Lane HLNE
Class A Common Stock
Directly977$84.98$83K0.1%Form 4, Sep 16, 2026

Share counts are the amounts Michael Schmertzler reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Michael Schmertzler's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
PTC Therapeutics PTCT
Common Stock
Through Section Six Partners, L.P.
Held by an investment fund or partnership
1,291,594$58.33$75.3M—Form 4, Oct 14, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 14, 2026SoldPTCT2,118$59.52$126KView
Oct 14, 2026SoldPTCT382$60.14$23KView
Oct 7, 2026SoldPTCT2,447$63.38$155KView
Oct 7, 2026SoldPTCT53$63.95$3KView
Sep 17, 2026SoldPTCT376$68.45$26KView
Sep 17, 2026SoldPTCT9,624$67.83$653KView
Sep 16, 2026SoldPTCT2,994$66.58$199KView
Sep 16, 2026SoldPTCT7,006$67.35$472KView
Sep 10, 2026SoldPTCT10,000$67.34$673KView
Sep 9, 2026SoldPTCT9,428$67.79$639KView
Sep 9, 2026SoldPTCT572$68.67$39KView
Aug 27, 2026SoldPTCT610$72.22$44KView
Aug 27, 2026SoldPTCT11,890$71.55$851KView
Aug 26, 2026SoldPTCT6,874$72.74$500KView
Aug 26, 2026SoldPTCT5,626$73.18$412KView
Aug 20, 2026SoldPTCT691$72.92$50KView
Aug 20, 2026SoldPTCT2,390$71.88$172KView
Aug 20, 2026SoldPTCT9,419$70.78$667KView
Aug 19, 2026SoldPTCT5,335$72.86$389KView
Aug 19, 2026SoldPTCT7,165$73.67$528KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2216Eric Wei
Director, CCC Intelligent Solutions Holdings. Boston, MA
$60.7M$0 (0.00%)
2217Sharps, Robert W
CEO and President, T. Rowe Price Group. Baltimore, MD
$60.7M−$2.8M (−4.42%)
2218Jennifer A. Parmentier
Chief Executive Officer, Parker-Hannifin. Cleveland, OH
$60.6M−$850K (−1.38%)
2219Michael Schmertzler
Director, PTC Therapeutics. Warren, NJ
$60.6M−$1.6M (−2.62%)
2220David M. Wehner
Chief Financial Officer, Meta Platforms. Pittsburgh, PA
$60.6M−$2.0M (−3.24%)
2221Michael Willis
Chief Financial Officer, Karman Holdings. Huntington Beach, CA
$60.5M−$2.2M (−3.51%)
2222Jonathan Hirt Hagen
Director, Erie Indemnity. Philadelphia, PA
$60.5M−$1.6M (−2.62%)

Other PTC Therapeutics insiders

All PTCT insiders

Questions

How much stock does Michael Schmertzler own?

Michael Schmertzler holds $60,593,515 in listed stock based on SEC filings and current prices, mostly Hamilton Lane (HLNE). That ranks 2219th on the Stock Rich List.

Is this Michael Schmertzler's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Michael Schmertzler last buy or sell stock?

The most recent open-market trade on file is a sale of 2,118 PTCT shares on Oct 14, 2026 at $59.52.